Zobrazeno 1 - 1
of 1
pro vyhledávání: '"James N. Atkins"'
Autor:
John C. Byrd, Thomas S. Lin, Margaret S. Lucas, Kathleen Donohue, Brian K. Link, Eva Hoke, Elizabeth M. Bengtson, James N. Atkins, Richard A. Larson, Kanti R. Rai
Publikováno v:
Blood. 114:210-210
Abstract 210 Background: Alemtuzumab (Campath-1H) is approved for the treatment of CLL. CALGB sought to determine whether alemtuzumab can improve the CR rate and eradicate MRD after induction chemoimmunotherapy by performing a phase II study administ